This inventor holds 3 USPTO granted patents. Top assignees: Medivir Ab, Astra Lakemedel Aktiebolag. Active years: 1985-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Jarna, SE (1985)
- Sodertalje, SE (1991)
- Pietra Ligure, IT (1993)
Company Filing History:
Years Active: 1985-1993
Title: Zsuzsanna M Kovacs: Innovator in Antiviral Pharmaceutical Composition
Introduction
Zsuzsanna M Kovacs is a notable inventor based in Sodertalje, Sweden. She has made significant contributions to the field of antiviral pharmaceuticals, holding a total of 3 patents. Her work focuses on innovative compositions that target viral infections, showcasing her expertise and dedication to advancing medical science.
Latest Patents
Among her latest patents is an antiviral pharmaceutical composition comprising 5-substituted pyrimidine. This composition utilizes a compound of a specific formula, wherein A is β-2'-deoxy-D-ribofuranosyl or β-D-arabinofuranosyl. Another significant patent involves derivatives of purine, which are antivirally active compounds characterized by a particular formula, where R1 is either hydrogen or hydroxymethyl. These patents reflect her commitment to developing effective antiviral treatments.
Career Highlights
Throughout her career, Zsuzsanna has worked with prominent companies in the pharmaceutical industry, including Medivir AB and Astra Lakemedel Aktiebolag. Her experience in these organizations has allowed her to collaborate with leading experts and contribute to groundbreaking research in antiviral therapies.
Collaborations
Zsuzsanna has collaborated with notable colleagues such as Karl N Johansson and Goran B Stening. These partnerships have further enriched her research and development efforts in the field of antiviral pharmaceuticals.
Conclusion
Zsuzsanna M Kovacs stands out as an influential inventor in the realm of antiviral pharmaceutical compositions. Her innovative patents and collaborations highlight her significant impact on medical research and the development of effective antiviral treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

